These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31435426)

  • 1. Whole-gland salvage treatment for recurrent prostate cancer after initial definitive radiotherapy: A case series of
    Sutani S; Yorozu A; Toya K; Nishiyama T; Ozu C; Yagi Y; Nakamura K; Saito S
    J Contemp Brachytherapy; 2019 Jun; 11(3):201-206. PubMed ID: 31435426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: toxicity, prostate-specific antigen kinetics, and cancer control.
    Mayrata E; Espinosa JM; Büchser D; Casquero F; Suárez F; González A; Minguez P; Pérez JF; Miguel IS; Cacicedo J; Gómez-Iturriaga A
    J Contemp Brachytherapy; 2021 Feb; 13(1):12-17. PubMed ID: 34025731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal versus whole gland salvage brachytherapy for recurrent prostate cancer in the prostate specific membrane antigen PET era: a narrative review.
    Andring LM; Teh BS; Butler EB; Farach AM
    Chin Clin Oncol; 2023 Jun; 12(3):26. PubMed ID: 37417290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity.
    Henríquez I; Sancho G; Hervás A; Guix B; Pera J; Gutierrez C; Abuchaibe O; Martínez-Monge R; Tormo A; Polo A
    Radiat Oncol; 2014 Apr; 9():102. PubMed ID: 24885287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer.
    Hsu CC; Hsu H; Pickett B; Crehange G; Hsu IC; Dea R; Weinberg V; Gottschalk AR; Kurhanewicz J; Shinohara K; Roach M
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):370-7. PubMed ID: 22672747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy.
    Henríquez López I; González-San Segundo C; Vegas JO; Gutierrez C; Hervas A; Cabeza Rodriguez MÁ; Valero Albarrán J; Rodríguez Villalba S; Álvarez Gonzalez A; Sancho Pardo G; Zapatero A; Álvaro PC
    Radiother Oncol; 2019 Dec; 141():156-163. PubMed ID: 31570236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy.
    Buchser D; Gomez-Iturriaga A; Melcon JI; Casquero F; Llarena R; Cacicedo J; Bilbao P
    J Contemp Brachytherapy; 2016 Dec; 8(6):477-483. PubMed ID: 28115952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage I-125 brachytherapy for locally-recurrent prostate cancer after radiotherapy.
    Pons-Llanas O; Burgos-Burgos J; Roldan-Ortega S; Conde-Moreno A; Celada-Alvarez F; Ruiz-Martinez JC; Lliso-Valverde F; Tormo-Micó A; Perez-Calatayud J; López-Torrecilla J
    Rep Pract Oncol Radiother; 2020; 25(5):754-759. PubMed ID: 32684865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes.
    Chen CP; Weinberg V; Shinohara K; Roach M; Nash M; Gottschalk A; Chang AJ; Hsu IC
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):324-9. PubMed ID: 23474112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of life.
    Peters M; Maenhout M; van der Voort van Zyp JR; Moerland MA; Moman MR; Steuten LM; van Deursen MJ; van Vulpen M
    Radiother Oncol; 2014 Jul; 112(1):77-82. PubMed ID: 24998704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage external beam radiotherapy for locally recurrent prostate cancer after definitive brachytherapy.
    Rutenberg MS; Meister M; Amin PP; Hussain A; Naslund MJ; Kwok Y
    Brachytherapy; 2016; 15(6):722-729. PubMed ID: 27693225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer.
    Burri RJ; Stone NN; Unger P; Stock RG
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1338-44. PubMed ID: 20138442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation.
    Meraouna Y; Blanchard P; Losa S; Labib A; Krhili S; Pommier P; Crehange G; Flam T; Cosset JM; Kissel M
    Clin Transl Radiat Oncol; 2024 Sep; 48():100809. PubMed ID: 39027689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints.
    Peters M; van der Voort van Zyp J; Hoekstra C; Westendorp H; van de Pol S; Moerland M; Maenhout M; Kattevilder R; van Vulpen M
    Radiother Oncol; 2015 Nov; 117(2):262-9. PubMed ID: 26349590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-Guided Ultrafocal Salvage High-Dose-Rate Brachytherapy for Localized Radiorecurrent Prostate Cancer: Updated Results of 50 Patients.
    van Son MJ; Peters M; Moerland MA; Lagendijk JJW; Eppinga WSC; Shah TT; Ahmed HU; van der Voort van Zyp JRN
    Int J Radiat Oncol Biol Phys; 2020 May; 107(1):126-135. PubMed ID: 32006609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity.
    Rose JN; Crook JM; Pickles T; Keyes M; Morris WJ
    Brachytherapy; 2015; 14(3):342-9. PubMed ID: 25727178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol-based image-guided salvage brachytherapy. Early results in patients with local failure of prostate cancer after radiation therapy.
    Lahmer G; Lotter M; Kreppner S; Fietkau R; Strnad V
    Strahlenther Onkol; 2013 Aug; 189(8):668-74. PubMed ID: 23824103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer.
    Lewis SL; Patel P; Song H; Freedland SJ; Bynum S; Oh D; Palta M; Yoo D; Oleson J; Salama JK
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):605-11. PubMed ID: 26867889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time.
    Kollmeier MA; McBride S; Taggar A; Anderson E; Lin M; Pei X; Weiji S; Voros L; Cohen G; Yamada Y; Zelefsky MJ
    Brachytherapy; 2017; 16(6):1091-1098. PubMed ID: 28838648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes.
    Barbera F; Triggiani L; Buglione M; Ghirardelli P; Vitali P; Caraffini B; Borghetti P; Greco D; Bardoscia L; Pasinetti N; Costa L; Maddalo M; Ghedi B; La Face B; Magrini SM
    Clin Med Insights Oncol; 2017; 11():1179554917738765. PubMed ID: 29151782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.